World Parkinson Congress Blog

Posts in Basic Science

LRRK2: It’s Not All About The Neurons

LRRK2: It’s Not All About The Neurons

by Darcie A. Cook and Malú G. Tansey, PhD

Basic ScienceDarcie A. Cook PhD CandidateJuly 24, 2017LRRK2, Genetics, Inflammation, Immune System, iPD, First

To Predict and Prevent

To Predict and Prevent

by Matthew Farrer, PhD

Basic ScienceMatthew Farrer, PhDJuly 17, 2017Micheal J Fox, PPMI, Genetics, LRRK2, GBA, July 2017, First

Developing disease-modifying therapies in Parkinson’s Disease: The buzz about LRRK2 kinase inhibitors

Developing disease-modifying therapies in Parkinson’s Disease: The buzz about LRRK2 kinase inhibitors

by Andrew B. West, PhD

Photo Credit: Grove Ayers

Basic ScienceAndrew B. West, PhDJuly 10, 2017LRRK2, Michael J Fox, PPMI, Genetics, July 2017, one, First

Bringing down the barriers: The Latin American Research consortium on the Genetics of Parkinson’s Disease (LARGE-PD)

by Ignacio F. Mata, PhD

Basic ScienceIgnacio F. Mata PhDJune 26, 2017Español, Spanish, Genetics, personalised medicine, LARGE-PD, genetic profile, Parkinson's Disease, parkinson, June 2017, one, First

Towards an Understanding of the Cognitive Changes in Parkinson's

Towards an Understanding of the Cognitive Changes in Parkinson's

by Javier Castro-Hernández, MD & David Finkelstein, PhD

Basic ScienceJavier Castro-Hernandez MDJune 16, 2017cognition, parkinson, ventral tegmental area, VTA, June 2017, one, First

The Flu and You: How Viruses Influence the Risk of Parkinson's

The Flu and You: How Viruses Influence the Risk of Parkinson's

by Richard Smeyne, PhD

Basic ScienceRichard Smeyne PhDMay 29, 2017virus, influenze virus, May 2017, One, one, First

“Tip-of-the-Iceberg” Opportunities in Parkinson’s Disease

“Tip-of-the-Iceberg” Opportunities in Parkinson’s Disease

by Madelyn C. Houser & Malú G. Tansey, PhD

(Photo of Madelyn Houser in the lab.)

Basic ScienceMadelyn C. Houser PhD CandidateMay 15, 2017neuroinflammation, neuroprotection, gut, gut microbiome, non-motor, May 2017, One, one, First

Breakthrough on the Horizon

Breakthrough on the Horizon

by Ted Dawson, MD, PhD

Basic ScienceTed Dawson MD, PhDMay 1, 2017c-Abl inhibitors, neuroprotection, disease modification, May 2017, one, First

Sweeter may be Bitter for Parkinson's Disease

Sweeter may be Bitter for Parkinson's Disease

by Tiago Fleming Outiero, PhD

Basic ScienceTiago Fleming Outiero, PhDApril 24, 2017Alpha-Synuclein, Enviromental risk factors, Therapies, Parkinson's, April 2017, one, First